Sleep Number (SNBR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Leadership transition announced: Linda Findley appointed as new President and CEO, effective April 7, 2025, succeeding Shelly Ibach, who is retiring after 18 years; Phillip M. Eyler to become independent Chair.
The company executed a significant operating model transformation over the past 18 months to enhance financial resilience amid a persistently weak mattress market.
Focused on cost reductions, margin improvement, and cash generation to offset top-line pressures from declining demand.
Q4 net sales declined 12% year-over-year to $377 million; full-year net sales down 11% to $1.68 billion.
Q4 adjusted EBITDA increased 43% year-over-year to $26 million; full-year adjusted EBITDA was $120 million, at the midpoint of guidance.
Financial highlights
Q4 net sales declined 12% year-over-year to $377 million; full year 2024 net sales were $1.68 billion, down 11% versus prior year.
Q4 gross margin rate reached 59.9% (up 330 bps YoY); full year gross margin was 59.6% (up 190 bps YoY).
Q4 operating income was $2.8 million, compared to a loss of $19.6 million last year.
Operating expenses reduced by $28 million in Q4 and $88 million for the full year.
Generated $4 million in positive free cash flow for the year, up $70 million from prior year.
Outlook and guidance
No formal 2025 financial outlook provided due to CEO transition; new guidance to be issued later.
Industry demand expected to remain pressured in the first half of 2025, with potential for improvement in the back half, though recent trends suggest a more conservative outlook.
Company remains focused on maximizing EBITDA, cash generation, and maintaining flexibility.
Latest events from Sleep Number
- Director elections and key business proposals passed; governance changes did not.SNBR
AGM 2026 - Q1 sales fell 19% to $319M, net loss widened, and turnaround actions and liquidity steps continue.SNBR
Q1 2026 - Shareholders to vote on board declassification, equity plan expansion, and governance reforms.SNBR
Proxy filing - Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 2025 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 2024 - Gross margin rose and cost cuts offset sales declines, supporting 2024 EBITDA guidance.SNBR
Q2 2024